| PERIOD ENDING | 31-Dec-01 | 31-Dec-00 | 31-Dec-99 | | Total Revenue | 9,258 | 9,629 | 10,626 | | Cost of Revenue | 2,746 | 2,830 | 3,299 | | | Gross Profit | 6,513 | 6,800 | 7,328 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 5,940 | 6,172 | 6,670 | | Non Recurring |
-
|
-
|
-
| | Others | 473 | 470 | 434 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 100 | 158 | 224 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 100 | 158 | 224 | | Interest Expense | 43 | 45 | 0 | | Income Before Tax | 57 | 113 | 223 | | Income Tax Expense | 14 | 24 | 86 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 43 | 89 | 137 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
| (96) |
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 43 | (7) | 137 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $43 | ($7) | $137 |
|
1.52% Nasdaq 0.00%
Income Statement
